These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 30394964)

  • 1. Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats.
    Fretellier N; Granottier A; Rasschaert M; Grindel AL; Baudimont F; Robert P; Idée JM; Corot C
    Invest Radiol; 2019 Feb; 54(2):61-71. PubMed ID: 30394964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.
    Rasschaert M; Emerit A; Fretellier N; Factor C; Robert P; Idée JM; Corot C
    Invest Radiol; 2018 Jun; 53(6):328-337. PubMed ID: 29329151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Speciation Analysis of Residual Gadolinium in Deep Cerebellar Nuclei in Rats Repeatedly Administered With Gadoterate Meglumine or Gadodiamide.
    Strzeminska I; Factor C; Jimenez-Lamana J; Lacomme S; Subirana MA; Le Coustumer P; Schaumlöffel D; Robert P; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2022 May; 57(5):283-292. PubMed ID: 35066532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.
    Robert P; Lehericy S; Grand S; Violas X; Fretellier N; Idée JM; Ballet S; Corot C
    Invest Radiol; 2015 Aug; 50(8):473-80. PubMed ID: 26107651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats.
    Robert P; Violas X; Grand S; Lehericy S; Idée JM; Ballet S; Corot C
    Invest Radiol; 2016 Feb; 51(2):73-82. PubMed ID: 26606549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents.
    Strzeminska I; Factor C; Robert P; Grindel AL; Comby PO; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2020 Mar; 55(3):138-143. PubMed ID: 31917763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year Retention of Gadolinium in the Brain: Comparison of Gadodiamide and Gadoterate Meglumine in a Rodent Model.
    Robert P; Fingerhut S; Factor C; Vives V; Letien J; Sperling M; Rasschaert M; Santus R; Ballet S; Idée JM; Corot C; Karst U
    Radiology; 2018 Aug; 288(2):424-433. PubMed ID: 29786486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Gadolinium Distribution of the New High-Relaxivity Gadolinium Chelate Gadopiclenol in a Rat Model of Severe Renal Failure.
    Fretellier N; Rasschaert M; Bocanegra J; Robert P; Factor C; Seron A; Idée JM; Corot C
    Invest Radiol; 2021 Dec; 56(12):826-836. PubMed ID: 34091462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of Gd in the protein content of the brain following single injection of gadolinium-based contrast agents (GBCAs) by size exclusion chromatography.
    Kartamihardja AAP; Hanaoka H; Andriana P; Kameo S; Takahashi A; Koyama H; Tsushima Y
    Br J Radiol; 2019 Jul; 92(1099):20190062. PubMed ID: 31045442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speciation Analysis of Gadolinium in the Water-Insoluble Rat Brain Fraction After Administration of Gadolinium-Based Contrast Agents.
    Strzeminska I; Factor C; Robert P; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2021 Sep; 56(9):535-544. PubMed ID: 33813574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
    Frenzel T; Apte C; Jost G; Schöckel L; Lohrke J; Pietsch H
    Invest Radiol; 2017 Jul; 52(7):396-404. PubMed ID: 28125438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion.
    Lancelot E
    Invest Radiol; 2016 Nov; 51(11):691-700. PubMed ID: 27175546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium Retention in the Central and Peripheral Nervous System: Implications for Pain, Cognition, and Neurogenesis.
    Alkhunizi SM; Fakhoury M; Abou-Kheir W; Lawand N
    Radiology; 2020 Nov; 297(2):407-416. PubMed ID: 32808889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model.
    Wang ST; Hua ZX; Fan DX; Zhang X; Ren K
    Biomed Res Int; 2019; 2019():3901907. PubMed ID: 31192255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Gadolinium-Based Contrast Agents on Longitudinal Changes of Magnetic Resonance Imaging Signal Intensities and Relaxation Times in the Aging Rat Brain.
    Green C; Jost G; Frenzel T; Boyken J; Schwenke C; Pietsch H
    Invest Radiol; 2022 Jul; 57(7):453-462. PubMed ID: 35125411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.
    Fretellier N; Bouzian N; Parmentier N; Bruneval P; Jestin G; Factor C; Mandet C; Daubiné F; Massicot F; Laprévote O; Hollenbeck C; Port M; Idée JM; Corot C
    Toxicol Sci; 2013 Jan; 131(1):259-70. PubMed ID: 22977165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of the Spatial Distribution of Gadolinium, Iron, Manganese, and Phosphorus in the Brain of Healthy Rats After High-Dose Administrations of Gadodiamide and Gadobutrol.
    Hummel L; Frenzel T; Boyken J; Pietsch H; Seeliger E
    Invest Radiol; 2024 Feb; 59(2):150-164. PubMed ID: 38157437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.